Each month, we compile and present a comprehensive up-to-date list of recently started clinical trials to keep you informed of the latest advancements and research in the medical field. To be the first to know about new clinical trials Register Now for free

The below are the clinical trials posted for the first time in July 2024.

Phase 4:

  1. Optimizing Subcutaneous FEntanyl titRation: RApid Achievement of Adequate Exposure When Treating Cancer-Related paIn.
  2. Methadone Versus Intrathecal Hydromorphone for Postoperative Pain Relief in Gynecologic Cancer Undergoing Surgery
  3. Evaluation of the Cardioprotective Effect of Dapagliflozin on Anthracyclines-Induced Cardiotoxicity in Breast Cancer Patients
  4. Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric Cancer
  5. Effect of Neoadjuvant Chemotherapy on Cardiac Function of Perioperative Patients With Breast Cancer and New Strategies for Anesthesia
  6. Effects of Minimal-Flow Sevoflurane and Multimodal Analgesia in Head and Neck Cancer Surgery
  7. Donafenib Combined With Immunotherapy and Local Therapy for Unresectable Hepatocellular Carcinoma That Has Failed in Previous Therapy
  8. Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma
  9. Combination Therapy of 5-Fluorouracil and CALcipotriol Versus 5-Fluorouracil in the Treatment of Actinic Keratosis

Phase 3:

  1. Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
  2. Comparison of Conventional and Hypofractionated IMRT in High-Risk Cervical Cancer Post-Radical Hysterectomy
  3. A Prospective Pivotal Study to Evaluate the Efficacy and Safety of AvastinΒ® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
  4. A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
  5. Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
  6. Node-sparing Short-Course Radiation Combined With CAPOX and Tislelizumab for MSS Rectal Cancer
  7. Phase III Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients
  8. Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCC
  9. Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer
  10. A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic Cancer
  11. The Sagittarius Trial
  12. Pre-Operative Window of ET to Inform RT Decisions (POWER II)
  13. Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP)
  14. Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)
  15. Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
  16. A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer
  17. Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer
  18. ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer
  19. FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer
  20. A Study Comparing BL-B01D1 With Topotecan in Patients With Recurrent Small Cell Lung Cancer
  21. Adjuvant FOLFIRI Based-chemotherapy After Resection of CLM Responding to Preoperative FOLFIRI
  22. Adjuvant PD-1 Blockade for High-risk Stage-II dMMR/MSI-H Colorectal Cancer
  23. The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT-GLOBAL)
  24. Lurbinectedin or in Combination With Irinotecan Versus Topotecan in Patients With Relapsed SCLC
  25. A Study of HS-20093 vs Active Surveillance in Limited-Stage Small Cell Lung Cancer
  26. Nutrition Impact on Immunotherapy of Cancer
  27. Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
  28. Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
  29. Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
  30. Olanzapine for Cancer Related Anorexia-cachexia Syndrome
  31. PHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver Metastases
  32. Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer
  33. JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC）
  34. Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT
  35. A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan Versus Sacituzumab Govitecan Alone in the Treatment of Advanced Urothelial Cancer
  36. A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Recurrent or Metastatic PD-L1+ Head and Neck Squamous Cell Carcinoma Patients
  37. A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients
  38. 2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma
  39. Online Adaptive Radiotherapy for Nasopharyngeal Carcinoma
  40. Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients
  41. Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients
  42. A Clinical Study Comparing SG301 Plus Pomalidomide and Dexamethasone to Placebo Plus Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients
  43. Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
  44. Astragalus for Symptomatic Alleviation in High-grade Lymphoma
  45. A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype
  46. The Efficacy and Safety of Pola-ZR2 Versus ZR2 in the Treatment of Old Patients With de Novo Diffuse Large B-cell Lymphoma
  47. A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
  48. Bendamustine and Rituximab With or Without Orelabrutinib in MCL Treatment
  49. Evaluate the Safety and Efficacy of Tafasitamab and Lenalidomide in Combination With Gemcitabine and Oxaliplatin Versus Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
  50. A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 75 Years With gMG.
  51. The Efficacy and Safety of Elritercept in Adult Participants With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) With Anemia (RENEW)

Phase 2-3:

  1. To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer
  2. Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
  3. Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors
  4. A Phase 2/3 Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal Cancer

Phase 2:

  1. Efficacy of Topical 85% TCA in the Treatment of LSIL After Low-grade Abnormality of Screening Test: a Randomized Controlled Trial
  2. Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3)
  3. Pharmacogenomics for Better Treatment of Fungal Infections in Cancer
  4. Safety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With Relapsed or Refractory B-Cell Neoplasms
  5. A Trial of Gemcitabine, Pembrolizumab and IMM-101 as First Line Treatment in Patients With Metastatic Pancreatic Cancer
  6. Neratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 Mutations
  7. Study of LTC004 Combine With Toripalimab in Patient With Solid Tumors Resistant to Immunotherapy
  8. Tirzepatide in Patients With Obesity or Overweight Who Have High Risk Early Breast Cancer and Are ctDNA+
  9. A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET)
  10. Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
  11. SHR-4602 for Injection in Subjects With HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors
  12. A Study to Evaluate the Efficacy of Osimertinib in Patients With EGFR-sensitive Mutated Non-small Cell Lung Cancer Progression After Receiving Adjuvant Targeted Therapy Following Radical Surgery
  13. Telehealth Intervention for Ostomy Self-Management
  14. Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
  15. Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.
  16. Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine Differentiation
  17. Induction Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer
  18. Tislelizumab in People With Colorectal Cancer
  19. Neoadjuvant Therapy With Weekly Utidelone Combined With Cisplatin for Patients With Breast Cancer (NeoURANIA)
  20. MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal Cancer
  21. Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
  22. Eliminating Breast Surgery for Breast Cancer Patients With Clinical Complete Response to Neoadjuvant Systemic Therapy
  23. Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer
  24. Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer
  25. Neoadjuvant Adebrelimab and Chemotherapy in High-rish ER+/HER2- BC
  26. Efficacy and Safety of Dalpiciclib Plus Toremifene in the Treatment of Advanced First-line HR Positive and HER2 Negative Breast Cancer: a Multicenter, Single Arm, Exploratory Phase II Clinical Study
  27. Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma.
  28. SCRT Followed by Camrelizumab Combined With Fluzoparib and Chemotherapy as Neoadjuvant Therapy for LARC
  29. Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer
  30. The Impact of Medication Timing Adjustment on the Effect of Novel Hormonal Therapy
  31. Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients
  32. Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour
  33. A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients
  34. First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without Nesuparib, in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient (pMMR) Endometrial Cancer
  35. Consolidative Radiotherapy (CSRT) in Patients With Oligometastatic/Locally Advanced Unresectable Bilary Tract Cancer (BTC)
  36. Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer
  37. A Prospective Study of MSS-type Metastatic Colorectal Cancer Receiving Multiple Lines of Standard Chemotherapy, Bevacizumab Combined With Adebrelimab
  38. 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
  39. Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer
  40. Durvalumab Combined With S-1 as Adjuvant Therapy of Resectable BTC
  41. Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
  42. Erdafitinib Monotherapy or in Combination With Cetrelimab in Muscle-invasive Bladder Cancer Patients With FGFR Gene Alterations
  43. A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients
  44. Neoadjuvant Long-course Chemoradiotherapy Followed by Immunotherapy for Locally Advanced Mid-low Rectal Cancer
  45. Race Impact on Efficacy of Niraparib Plus Abiraterone Acetate and Prednisone in Patients With Homologous Repair Deficient Castration-resistant Prostate Cancer
  46. RC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric Cancer
  47. A Clinical Study of 9MW2821 (and PD-1 Inhibitor) in Locally Advanced or Metastatic Triple-Negative Breast Cancer
  48. Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal Metastasis
  49. A Study of RadspherinΒ® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
  50. Evaluate Efficacy of Devimistat in Combination With mFFX in 2nd Line Patients With Metastatic Pancreatic Cancer
  51. Chemotherapy Plus EGFR Monoclonal Antibody in Patients With Liver Metastases From Colorectal Cancer With ctDNA Superselective Negative Genes
  52. Study Evaluating Tarlatamab in Chinese Participants With Advanced Small Cell Lung Cancer After Two or More Prior Lines of Treatment
  53. Intrathecal Pemetrexed for SCLC Patients With Refractory Brain Metastases or Leptomeninges Metastatic
  54. TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors
  55. Standard Systemic Therapy Combined With High/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer
  56. Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cancer (BrightStar-2)
  57. Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety
  58. Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Stable Brain Metastasis
  59. A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality
  60. Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion Mutations
  61. A Study of QL1706 (an Anti-PD-1/CTLA-4 Combined Antibody) Combined With Albumin-bound Paclitaxel and Bevacizumab in the Treatment of Platinum-resistant Recurrent Ovarian Cancer
  62. A Study of BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
  63. A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents With Advanced NUT Cancer
  64. Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery
  65. Adaptive Therapy With Capecitabine for the Treatment of Metastatic Estrogen Receptor Positive, HER2 Negative Breast Cancer
  66. Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma
  67. Prospective Phase II Study on Continuous Circumferential Reinforcement of Laparoscopic Rectal Anastomosis to Prevent Complications
  68. Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC
  69. N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
  70. Sequential Immunochemotherapy Treatment With Pembrolizumab Plus Dendritic Cell (DC) Vaccine Followed by Trifluridine/Tipiracil Plus Bevacizumab in Refractory Mismatch-repair-proficient (pMMR) or Microsatellite-stable (MSS) Metastatic Colorectal Cancer
  71. First-Line Treatment Induced With mFOLFOX6 and HLX04 Regimen, Following Combined With Serplulimab in MSS Initially Unresectable Metastatic Colorectal Cancer
  72. Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer
  73. Avelumab and M1774 in ARID1A-mutated Endometrial Cancer (Prior IO)
  74. AZD4205 in Relapsed or Refractory Peripheral T Cell Lymphoma (JACKPOT27)
  75. Neoadjuvant Treatment of gBRCA-Mutated HER2-Negative Breast Cancer With HRS-1167 and Famitinib Β± Camrelizumab
  76. AZD4205 in Peripheral T Cell Lymphoma Following First-Line Therapy (JACKPOT26)
  77. Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer
  78. A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel（Albumin Bound）Verse Docetaxel for the Treatment of MET-overexpressed Non-small Cell Lung Cancer
  79. ACOU085 for Hearing Loss Prevention in Testicular Cancer Patients Receiving Cisplatin
  80. A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer
  81. Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)
  82. Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer
  83. Pilot Trial of Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma
  84. Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer.
  85. High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
  86. Neoadjuvant Serplulimab in Combination With Chemotherapy in Locally Advanced Gastric or Gastro-esophageal Junction Cancer
  87. A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer Patients
  88. Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial
  89. Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow
  90. A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)
  91. Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
  92. Toripalimab Combined With Targeted Therapy and Chemotherapy With or Without Radiotherapy as First-Line Treatment for Advanced Colorectal Cancer
  93. Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer
  94. Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations
  95. Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Active Brain Metastasis
  96. Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract Carcinoma
  97. Trilaciclib Prevents Myelosuppression With Chemoradiotherapy
  98. A Multicenter Randomized Controlled Study of Interventional Treatment for Operable Stage β…΅-β…Ά Non-small Cell Lung Cancer With Potential Recurrence as Minimal Residual Disease(MRD) Positive
  99. A Phase II Study of MRG003 Injection Combined With Pucotenlimab Injection Β± Cisplatin Injection in the Neoadjuvant Treatment Locally Advanced EGFR-positive Head and Neck Squamous Cell Carcinoma
  100. A Phase II Study of Anti-EGFR Antibody-drug Conjugate (ADC) Combine With CDK4/6 Inhibitors Posterior Line in the Treatment of Recurrent/Metastatic CDKN2A Gene Variant Head and Neck Squamous Cell Carcinoma
  101. AK117 (Anti-CD47) + Anti-EGFR for R/M HNSCC
  102. AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic Therapy
  103. A Study of Simmitinib Plus Irinotecan in Advanced Esophageal Squamous Cell Carcinoma
  104. Adebrelimab Β±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC
  105. Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma（CRIS-2 Trial）
  106. Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC
  107. An Exploratory Study of Lurbinectedin With Radiotherapy in Locally-advanced SCLC After First-line Therapy
  108. Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma
  109. GP Combined With Nimotuzumab and Sintilimab as Induction Therapy for Nasopharyngeal Carcinoma
  110. A Phase 2 Open-label Single-arm Trial of JAK1 Inhibitor for the Treatment of Large Inflammatory Hepatocellular Adenomas
  111. Single High-dose Brachytherapy for Giant Osteosarcoma Masses
  112. Cryoablation Combined With PD-1 Antibody and Bevacizumab for Hepatocellular Carcinoma
  113. Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone
  114. Neoadjuvant SBRT Combined With Lenvatinib and Pucotenlimab for Resectable Hepatocellular Carcinoma
  115. Donafenib Combine With Sintilimab and HAIC in Neoadjuvant of Resectable Hepatocellular Carcinoma
  116. Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab
  117. Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis
  118. A Phase II Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
  119. An Investigational Scan (Ga-68 PSMA-11 PET/CT) for the Detection of Therapy Response in Patients With Metastatic Adenoid Cystic Carcinoma
  120. Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma.
  121. A Phase 2 Study Using Aliya PEF Plus Pembro for Sarcoma
  122. Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
  123. Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy
  124. Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD
  125. Phase II Study of Sonrotoclax Combined With Chemotherapy in the Treatment of Newly Diagnosed Acute Myeloid Leukemia
  126. Nivolumab in Multiple Myeloma Patients After Idecabtagene Vicleucel
  127. Bispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients
  128. A Study to Evaluate Preventive Treatments for Talquetamab-related Oral Toxicity
  129. Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML
  130. Interferon-Ξ³ (IFN-Ξ³) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
  131. AZD0486 as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
  132. A Phase 2 Study of Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a Complete Response With Upfront Chemoimmunotherapy
  133. Polatuzumab, Rituximab and Orelabrutinib Combination Regimen (PRO) in the Treatment of Elderly Frail Patients With Treatment-naive Non-GCB DLBCL
  134. GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Previously Untreated Mantle Cell Lymphoma
  135. Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma
  136. A Study Comparing the Efficacy and Safety of Pola-RCHP-X Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With DLBCL
  137. Obinutuzumab, Zanubrutinib, and Lenalidomide Followed Short-Cycle of Obinutuzumab and Cytarabine in Newly Diagnosed Mantle Cell Lymphoma
  138. The Treatment of Ocular Adnexal Extranodal Marginal Zone B-cell Lymphoma by Orelabrutinib and Radiotherapy
  139. Zanubrutinib and Lenalidomide as Maintenance Therapy in DLBCL
  140. Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
  141. Study With Mosunetuzumab and Zanubrutinib in R/R Follicular Lymphoma Patients
  142. Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL
  143. Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial)
  144. Efficacy of Risk-Stratified Treatment in Newly Diagnosed Infant Leukemia
  145. A Phase 2 Study WU-CART-007 in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
  146. Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.
  147. Toripalimab Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma
  148. A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Hyaluronidase (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65)
  149. Epcoritamab in Previously Treated WM
  150. Combination of Orelabrutinib and Obinutuzumab in Untreated Marginal Zone Lymphomas
  151. A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma
  152. Optimize Study - Orelabrutinib Combined With BR/G in Untreated Marginal Zone Lymphoma (MZL)
  153. Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia
  154. Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/Anti-LGI1 Encephalitis
  155. Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple Myeloma
  156. PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
  157. A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-Line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-Treatment Period
  158. A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
  159. M-CHOP in RichterΒ΄s Syndrome
  160. Vitamin A and D Supplementation in Allogeneic HCT
  161. Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

Phase 1-2:

  1. Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms
  2. A Study of HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid Tumors
  3. A Phase 1/2 Study of SMP-3124LP in Adults With Advanced Solid Tumors
  4. Lamivudine for Solid Tumors
  5. A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors
  6. Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia
  7. A Phase Ib/II Study of BY101298 , an Oral DNA-PK Inhibitor, Combined With Radiotherapy in Patients With Malignant Solid Tumors
  8. A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations
  9. Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer
  10. A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer
  11. EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors
  12. Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic Cancer
  13. A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
  14. A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies
  15. A Study to Investigate Natural Killer Cell Engager (SAR443579) With Different Agents in Participants With Hematological Malignancies
  16. Hypofractionated Radiotherapy Combined With Immunotherapy for Limited-stage Small-cell Lung Cancer
  17. [18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer
  18. CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors
  19. Immunosurveillance for Metastatic Colorectal Cancer
  20. A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer
  21. Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts
  22. Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer
  23. DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma
  24. Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
  25. Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
  26. Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma
  27. Study of Bemcentinib Plus Pacritinib In Patients With Advanced Lung Adenocarcinoma
  28. A Phase Ib/II Study of AK112 (PD-1/VEGF Bispecific Antibody) in Combination Therapy for Patients With Advanced Hepatocellular Carcinoma (HCC).
  29. Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular Carcinoma
  30. Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation
  31. Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM
  32. Nanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMM
  33. Polyspecific Antibodies in Lymphoproliferative T-cell Disorders
  34. Efficacy of Mazdutide for Treating PCOS

Phase 1:

  1. A Study Evaluating Single-agent Inavolisib and Inavolisib Plus Atezolizumab in PIK3CA-Mutated Cancers
  2. A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers
  3. Safety, Tolerability and Preliminary Efficacy of Erythrocyte-Ξ±PD-1 Conjugate in Patients With Advanced Malignancies
  4. Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors
  5. A Single Arm Clinical Study of Dendritic Cell Vaccine Loaded With Circular RNA Encoding Cryptic Peptide for Patients With HER2-negative Advanced Breast Cancer
  6. M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)
  7. A Clinical Trial of SIBP-A17 Injection in the Treatment of Advanced Solid Tumor Patients.
  8. A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
  9. MAQ-001 in Patients With Advanced Solid Tumors
  10. A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
  11. A Study of BL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors
  12. A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Negative Breast Cancer and Other Solid Tumors
  13. A Study of BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors
  14. Anti-CDH17 CAR-T Cell Injection in Patients With CDH17-positive Advanced Malignant Solid Tumors
  15. Treatment of Cancer With Immune Checkpoint Inhibition Therapy Boosted by High Intensity Focused Ultrasound Histotripsy
  16. A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors
  17. ETC-159 In Combination With Pembrolizumab In Advanced MSS/pMMR Ovarian Cancers
  18. A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
  19. A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
  20. Clinical Study of XP-004 Personalized mRNA Tumor Vaccine Combined With PD-1 Inhibitor for Postoperative Adjuvant Therapy for Pancreatic Cancer in Patients With Advanced Solid Tumors
  21. Food Effect and Relative Bioavailability Study of VC004 Capsules in Healthy Adult Subjects
  22. Neoadjuvant Chemotherapy With WH002 in Women With HER2-negative Breast Cancer
  23. Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer
  24. A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
  25. A Study of DM005 in Patients With Advanced Solid Tumors
  26. Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
  27. A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients
  28. Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
  29. Phase I Trial of MT-0169 in CD38+ Acute Leukemia With Relapsed/Refractory or Measurable Residual Disease
  30. Autologous Tumor-Infiltrating Lymphocyte (GTE-001 Injection ) for Treatment of Patients With Advanced Lung Adenocarcinoma
  31. Low-dose Radiotherapy Plus Tislelizumab in Combination With Afatinib for Neoadjuvant Treatment of Surgically Resectable Head and Neck Squamous Carcinoma
  32. Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
  33. Study With [225Ac]Ac-FL-020 in mCRPC Participants
  34. HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors
  35. Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Reconstitution in Multiple Myeloma Patients After Autologous Hematopoietic Cell Transplant
  36. Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma
  37. Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML
  38. A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer
  39. Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid Carcinoma
  40. Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood Collection
  41. Induction IBI110 and Sintilimab With Chemotherapy In LA HNSCC
  42. Phase 2 Study: OBI-833/OBI-821 Maintenance for Globo H+ Advanced Biliary Tract Cancer After Gemcitabine/Cisplatin
  43. Targeted Survivin DC Cell Injection for the Treatment of GBM
  44. A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma
  45. ONO-7475-03: ONO-7475 Phase I Study An Open-label, Uncontrolled Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer
  46. A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy
  47. Liposomal Irinotecan With Cisplatin and Concurrent Radiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma
  48. Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma
  49. A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma
  50. Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
  51. On the Safety, Tolerability, and Efficacy of UTAA09 Injection in the Treatment of Lymphoma
  52. A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
  53. PET Imaging Study of 64Cu-GRIP B for Patients Receiving CD19-directed CAR-T Therapy
  54. An Open-label, Single-arm Study of JWCAR201 in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
  55. DR-18 for the Treatment of Relapsed or Persistent Acute Myeloid Leukemia or Myelodysplastic Syndrome After Hematopoietic Cell Transplantation, the DR. DREAM Trial
  56. Study of HS-10382 Combination in Patients With Chronic Myeloid Leukemia (CML)
  57. Blinatumomab and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL
  58. A Study of LCAR-HL30 in Subjects With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma
  59. Iadademstat With Hypomethylating Agent in Patients With Myelodysplastic Syndrome

Early Phase 1:

  1. An Exploratory Clinical Study Evaluating the Safety and Efficacy of Intravenous Anti-CD20/CD30-CAR-T Cell Infusion in Relapsed/Refractory Lymphoma Patients.
  2. Genetically Modified T Cells Treating Malignant Tumors
  3. An Exploratory Study of Individualized Neo-antigen mRNA Cancer Vaccine InnoPCV in Advanced Solid Tumor Treatment
  4. 68Ga-NTA-476 Imaging in Prostate Cancer
  5. Mirtazapine for Acute and Chronic Post Mastectomy Pain
  6. A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (PluvictoΒ®) in Patients With Metastatic Prostate Cancer
  7. A Trail of Second-line Chemotherapy Sequential NKG2D CAR-NK Cell Therapy for Pancreatic Cancer
  8. Effect of HIPEC After Radical Surgery on Long-term Survival for Locally Advanced Gastric Cancer
  9. PhI Pilot Study Pafolacianine Injec for Intraoperative Imag Gastrointestinal Can Peritoneal Carcinomatosis
  10. JY231(JY231) Injection for the Treatment of B-cell Acute Lymphoblastic Leukemia(B-ALL)

Phase Not Applicable:

  1. Clinical Study of Tumor Polypeptide DC-CTL in the Treatment of Solid Tumors
  2. Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients (HKCH)
  3. Dexamethasone Versus Mg Added to Bupivacaine Used in ESPB for Perioperative Pain Control in Patients Undergoing Unilateral Nephrectomy
  4. The Evolution of Neuroendoscopy Guided by Head-mounted Mixed Reality Technique Navigation System in Neurosurgery
  5. Comparing the Impact of Four Types of Meditation Practices for Relaxation in Cancer Survivors
  6. Stereotactic Body Radiation Therapy After Chemotherapy for Unresectable Perihilar Cholangiocarcinoma
  7. Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GIST
  8. Comparing Quality of Recovery Between ESPB and IV Lidocaine After Major Breast Cancer Surgery
  9. Support Pathway for ENT Cancer Patients in a Support Care Day Hospital
  10. Increasing Knowledge and Interest in Cancer Clinical Trials
  11. Miss Rate of Gastric Neoplasms Under Computer-aided Endoscopy
  12. Probiotics for the Prevention of Immunotherapy Induced Colitis in Patients Receiving Immunotherapy
  13. Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings
  14. LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes
  15. Broadband Collaborative Pulse Ablation Instrument Treating Malignant Pulmonary Nodules
  16. Benefit of Cone-beam CT and Robotic-Assisted Bronchoscopy During Bronchoscopy
  17. Foot Bath Effects on Chemotherapy-Induced Fatigue in Pediatric Oncology
  18. Positive Psychotherapy Balance Model Based Psychoeducation for Caregivers of Oncology Patients
  19. Dyadic Life Review Intervention for Older Patients With Advanced Cancer) and Their Caregivers
  20. A Multicenter Randomized Controlled Study of Photoelectric Detection in Cervical Cancer Screening
  21. Effect of Stress Ball on Perceived Stress, Pain and Satisfaction in Cancer Patients
  22. Collaborative cOMMUNIty Care for Metastatic breAsT cancEr Patients in inDonesia (Communicated)
  23. IMPLEMENT - Model Project for Quality-assured Exercise Therapy for Cancer Patients
  24. Airwave Compression Therapy to Prevent Breast Cancer-related Lymphedema
  25. Bliss DTx Assessment During Course Care Including Port-A-Catheter Setting
  26. Nutrition and Exercise Program for Elderly Colorectal Cancer Patients
  27. German-funded Laparoscopic Approach to Cervical Cancer
  28. Contact Radiotherapy for Rectal Cancer
  29. Clinical Application of AI-assisted Ultrasound Technology in the Preoperative Evaluation of Thyroid Cancer
  30. Physiotherapy Program Impact on Breast Cancer-Related Lymphedema
  31. Optic Nerve Stimulation To Prevent Visual Deficits After Endoscopic Cranial Approaches
  32. Technologies to Improve QoL of Prostate Cancer
  33. CALM Psychotherapy in Patients With Metastatic Cancer in Chile
  34. Application of Rapid On-site Evaluation in Lymph Node Biopsy of Breast Cancer
  35. Intervention With General Practitioners to Improve Women's Participation in Cervical Cancer Screening
  36. Effects of Physical Exercise on Response to Treatement in Breast Cancer
  37. FUS-TB VS COG-TB in Small Lesions of Prostate Cancer
  38. A Clinical Study of Albumin-bound Paclitaxel/Granulocyte-based Therapy for Recurrent/Metastatic Breast Cancer
  39. Goal-directed Enteral Nutritional Perioperative Management
  40. Adaptation and Pilot Testing of a Mindfulness-Based Insomnia and Symptom Management Intervention for Women With Breast Cancer Receiving Treatment in Rural Medically Underserved Areas
  41. Rein 3D PRINT MECHANICS
  42. Development of the Wearable Arm Volume Measurement Device and Mobile Application
  43. Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Military Population: The Sentinel Study
  44. Exercise as Maintenance Therapy in Advanced Lung Cancer
  45. The Effect of Motivational Interviewing Based on the COM-B Model
  46. Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era
  47. Reiki Breast Surgery QOL Project for Women Undergoing Breast Surgery
  48. Ablative SBRT in Elderly BC Patients
  49. Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer
  50. Autologous Tumor-Infiltrating Lymphocyte Injection(GT201) for Treatment of Patients With Advanced Lung Cancer
  51. Exercise Intervention in Women Diagnosed With Triple-negative Breast Cancer Receiving Oncologic Treatment
  52. Laser Speckle Imaging During Breast Reconstruction
  53. BarrigelΒ® PPRT (Post-Prostatectomy Radiation Therapy) Trial
  54. Community Health Navigator Program to Promote Cancer Screenings Among DDBHH People
  55. Research of the Application of Artificial Intelligence Model "PANDA"
  56. Probiotics for Depression in Cancer Patients
  57. Culinary Medicine for Cancer Caregivers
  58. Effect of Esketamine on Anxiety State in Patients Undergoing Abdominal Tumor Surgery
  59. Clinical Study on Intraluminal Injection of FOLactis
  60. The COMPASSION Study
  61. Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.
  62. Testing a Mammography Decision Intervention in a Rural Setting
  63. Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation
  64. Radiotherapy Patient Education With Virtual Reality
  65. Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer
  66. The Role of Short Course of Palliative Radiation in Metastatic Cancer Rectum
  67. Preventing Breast Cancer Therapy-related Cardiovascular Toxicity With a Daily-adapted Program With Mhealth Support
  68. LonsurfΒ® (Trifluridine/Tipiracil) Plus Chemotherapy in Metastatic Colorectal Cancer Prospective Study in Taiwan
  69. A RCT of Psychosocial Interventions Facilitating Positive Psychological Adaptation in Breast Cancer
  70. Cognitive Behavioral Therapy for Cancer-related Fatigue in Patients With Cancer Receiving Palliative Systemic Treatment
  71. Danish Vulva Cancer Recurrence Study
  72. PRISM for Depression and Anxiety in Young Adults With Cancer
  73. Whole Course Multi-model Prehabilitation to Improve Clinical Outcome in Patients Undergoing Neoadjuvant Treatment Prior to Gastrectomy
  74. Simple Simulation Based Breast Cancer Awareness Training
  75. NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors
  76. STereotactic Body Radiotherapy (SBRT) for Oligoprogressive Breast Cancer
  77. Transthoracic vs Transbronchial Ablation for Lung Cancer
  78. Augmented Reality Feasibility for Non-invasive Preoperative Tracking in Breast Cancer Surgery
  79. Informing Pain Treatment Using Pharmacogenomic Analysis
  80. Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY Trial
  81. The Real World Study of Pyrotinib in the Treatment of Advanced Breast Cancer With HER2 Positive
  82. Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association With Disease Stage
  83. NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer
  84. Effect of Pelvic Rehabilitation After Low Anterior Resection for Cancer Rectum. - A Randomised Controlled Trial
  85. Vulnerability and Risk of Neuropathic Pain in Cancer
  86. Self-acupressure and Zhan Zhuang for Symptom Cluster Management
  87. Nerve Grafting Technique to Preserve Erectile Function in Patients Undergoing Robotic Assisted Radical Prostatectomy
  88. Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening
  89. The Effect of Motivational Interviewing in Women's Health
  90. The Anti-reflux Effect of Double-flap Technique in Laparoscopic Proximal Gastrectomy.
  91. BINGO: Bridging Knowledge, Increasing Awareness
  92. Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)
  93. STEpwise Research Program to Promote INGeniouS ONline Supportive Solutions in the Relief of Cancer-related Fatigue (STEPPING-STONe)
  94. Feasibility of Prospective Surveillance and Early Physical Therapy for Trismus
  95. Evaluation of Brain Metastases Treated With Stereotactic Radiotherapy Using Dynamic [18F]FDG PET
  96. A Study on Efficacy and Safety of iNK Cells for CAEBV /EBV-HLH After Allo-HSCT
  97. Identification of Olfactory Biomarkers of Skin Cancer From Skin Odor Samples: a Pilot Study
  98. Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
  99. Effects of Acupressure and Aromatherapy on Nausea and Vomiting Severity, Anxiety and Comfort Level
  100. Prevalence of Long-term Dental Effects of Chemotherapy in Childhood Cancer Survivors Diagnosed With Cancer Before the Age of 10
  101. Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial
  102. AI as an Aid for Weekly Symptom Intake in Radiotherapy
  103. Two-Fraction Ultrahypofractionated Radiotherapy With Focal Boost for Intermediate Risk, Localized Prostate Cancer
  104. Key Interventions to Improve the Follow-up Adherence Post Cervical Precancerous Lesion Treatment in Ethiopia: A Pragmatic RCT
  105. Cuff Shape and Postoperative Sore Throat in Breast Cancer Patients
  106. PipelleΒ® Under Ultrasound Guidance (PUG) to Investigate Post-menopausal Bleeding.
  107. Binaural Sound for Remimazolam Maintenance
  108. Blood Biomarkers Based Screening for HPV-driven OPC
  109. Feasibility of Primer Shot Radiotherapy for Non-small Cell Lung Cancer - PRIMER
  110. MBC Physical Activity Study
  111. Improving Therapeutic Adherence in Cardiovascular Secondary Prevention.
  112. Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivors
  113. A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer
  114. Analgesic Efficacy of Erector Spinae Plane Block vs External Oblique Intercostal Plane Block in Subcostal Cancer Surgeries
  115. A Pilot Study Investigating Upfront Adaptive Immunotherapy Approach in Children, Adolescent and Young Adult (CAYA) Patients With Replication-Repair Deficient (RRD) High-Grade Gliomas (HGG)
  116. 18F-FET-PET/MRI vs Standard MRI Alone for Stereotactic RadioTherapy Planning for High Grade Brain Gliomas
  117. A Study on the Efficacy of Androgen Deprivation Therapy Combined With Anti-PD-1 Therapy in Advanced Lung Cancer
  118. Concordance and Acceptability of Self-screening Versus Screening by a Healthcare Professional for HPV, a Risk Factor for Anal Cancer, by Swab in People Living With HIV
  119. Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
  120. Effectiveness of Pelvic Floor Exercise to Prevent LARS (Low Anterior Resection Syndrome)
  121. Sacral Neuromodulation for Male Overactive Bladder (MOAB)
  122. Clinical Study of Lewis Antigen Assay Combined With CA19-9 Assay to Assess Prognosis in Patients With Pancreatic Cancer
  123. the DISC-OVARY Trial
  124. Segmentectomy After Induction Therapy (SAINT)
  125. Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line Treatment
  126. LevineConservationModelandColorectalPatients
  127. Efficacy of Serratus Posterior Intercostal Plane Block for Analgesia and Inflammatory Marker in Breast Surgery
  128. Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma
  129. EXTRA-Meso (EXercise TheRApy in Mesothelioma) Feasibility
  130. Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose Chemoradiotherapy for Newly Diagnosed Operable Nasopharyngeal Carcinoma.
  131. Safety and Efficacy Study of Lenvatinib Combined With VIC-1911 for the Treatment of Advanced HCC
  132. Prospective Real-World Study of HAIC With Raltitrexed or 5-Fluorouracil for the Treatment of Hepatocellular Carcinoma
  133. Texture and Colour Enhancement Imaging in Improving Detection and Miss Rate of Premalignant Lesions
  134. IRB 19065 - CMV-MVA Triplex Vaccine After Letermovir in HCT Recipients
  135. 68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas
  136. Evaluation of Risk of hEpatocellular Carcinoma
  137. 68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma
  138. Safety and Efficacy of Anti-BCMA-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM
  139. Integrative Therapies in Multiple Myeloma
  140. A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)
  141. Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma
  142. Allo-PBSCT as the First-line Treatment for Patients With the High-risk PTCL
  143. Methyl Aminolevulinate 8% and 16% Incubated by 1 and 3 for Actinic Keratoses Treatment
  144. Antibody-mediated LGI1 Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Chronic Phase of the Disease
  145. Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis
  146. Pilonidal Sinus Disease
  147. Effect of Ultrasound-guided Erector Spinae Plane Block on Postoperative Pain and Sleep Quality of Infants With Congenital Pulmonary Cystic Disease After Thoracoscopic Surgery
  148. Combination Letrozole and Clomiphene Citrate Versus Letrozole Alone
  149. Effect of Ultrasound Cavitation Versus Electrolipolysis on Obese Infertile Women With Polycystic Ovarian Syndrome


Note

The above Clinical Trial information has been retrieved from ClinicalTrials.gov